New nanoparticle SARS-CoV-2 vaccine confers robust protection with single dose after two weeks
In a methodologically ‘state-of-the-art’ approach, US researchers have developed a protein-based nanoparticle vaccine against coronavirus disease (COVID-19), with a swift
Read more